CDC Health Advisory: Patients Receiving Eculizumab (Soliris庐) at High Risk for Invasive Meningococcal Disease Despite Vaccination

July 7, 2017

Per an early release of the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR), new information was released today regarding聽Eculizumab (Soliris庐) in patients with the rare blood disorders,聽paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Read the MMWR article in full here.  

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.